🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
PREMIERE parallel, non-comparative, two-arm, randomized 1:1, open-label, mu...
Status
Recruiting
Location
ICO Badalona
Start Date
2023-02-03
Trial ID
NCT05982093
Treatments Being Tested
Considering the compelling amount of studies focused on patients in the act...
Status
Recruiting
Location
Federico II University of Naples
Start Date
2022-01-27
Trial ID
NCT05293366
Treatments Being Tested
Ovarian cancer (OC) is one of the most lethal cancers in the world due to l...
Status
Recruiting
Location
Catharina Hospital
Start Date
2025-01-01
Trial ID
NCT06611072
Treatments Being Tested
Background: Due to the remarkable improvement in treatments these last dec...
Status
Active Not Recruiting
Location
Geneva University Hospitals
Start Date
2015-06
Trial ID
NCT03180827
Treatments Being Tested
The study aims to develop a test for early detection of ovarian cancer usin...
Status
Recruiting
Location
University of Arkansas for Medical Sciences
Start Date
2020-04-13
Trial ID
NCT04794322
Treatments Being Tested
The protocol aims at demonstrating the technical feasibility and safety of ...
Status
Completed
Location
Institut Paoli Calmettes
Start Date
2014-07
Trial ID
NCT02221076
Treatments Being Tested
This is a combined prospective and retrospective observational study aiming...
Status
Recruiting
Location
Department of Pharmacology, Yonsei University College of Medicine
Start Date
2024-08-21
Trial ID
NCT07035587
Treatments Being Tested
This partially randomized phase I/II trial studies the side effects and the...
Status
Active Not Recruiting
Location
Cedars-Sinai Medical Center
Start Date
2010-04-14
Trial ID
NCT01116648
This is a single center, prospective, controlled pilot safety research stud...
Status
Suspended
Location
TRIO
Start Date
2016-10
Trial ID
NCT03021915
Treatments Being Tested
The receptor tyrosine kinase AXL is a pathway that plays a crucial role in ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-06-30
Trial ID
NCT03607955